Federal contract award
75A50424C00006
OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC) |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $26.5M |
| Current contract value | $26.5M |
| Potential contract value / ceiling | $26.5M |
| Start date | Sep 5, 2024 |
| Current end date | Apr 2, 2025 |
| Potential end date | Apr 2, 2025 |
| Latest award activity | Apr 2, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 2, 2025 | P00002 | $0 | EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING::EOI MODIFICATION TO TERMINATE FOR CONVENIENCE |
| Nov 4, 2024 | P00001 | $0 | OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.